A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Pfizer
Pfizer
Pfizer
Stanford University
Jonsson Comprehensive Cancer Center
Degron Therapeutics Co.
M.D. Anderson Cancer Center
Ikena Oncology
Jonsson Comprehensive Cancer Center
Eli Lilly and Company
Columbia University
National Cancer Institute (NCI)
ABM Therapeutics Corporation
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Celgene
SWOG Cancer Research Network
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Case Comprehensive Cancer Center